975 related articles for article (PubMed ID: 33053430)
1. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
2. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; McGary H; Razmpour R; Galie PA; Potula R; Andrews AM; Ramirez SH
bioRxiv; 2020 Jun; ():. PubMed ID: 32587958
[TBL] [Abstract][Full Text] [Related]
3. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
Kim ES; Jeon MT; Kim KS; Lee S; Kim S; Kim DG
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696455
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells.
Jana S; Heaven MR; Alayash AI
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445747
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human plasma gelsolin reverses increased permeability of the blood-brain barrier induced by the spike protein of the SARS-CoV-2 virus.
Suprewicz Ł; Tran KA; Piktel E; Fiedoruk K; Janmey PA; Galie PA; Bucki R
J Neuroinflammation; 2022 Nov; 19(1):282. PubMed ID: 36434734
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation.
DeOre BJ; Tran KA; Andrews AM; Ramirez SH; Galie PA
J Neuroimmune Pharmacol; 2021 Dec; 16(4):722-728. PubMed ID: 34687399
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Aβ
Hsu JT; Tien CF; Yu GY; Shen S; Lee YH; Hsu PC; Wang Y; Chao PK; Tsay HJ; Shie FS
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360989
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells.
Choi JY; Park JH; Jo C; Kim KC; Koh YH
Biochem Biophys Res Commun; 2022 Oct; 626():66-71. PubMed ID: 35970046
[TBL] [Abstract][Full Text] [Related]
10. SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation.
Reynolds JL; Mahajan SD
J Neuroimmune Pharmacol; 2021 Mar; 16(1):4-6. PubMed ID: 33405097
[No Abstract] [Full Text] [Related]
11. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A
Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863
[TBL] [Abstract][Full Text] [Related]
13. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.
Perico L; Morigi M; Galbusera M; Pezzotta A; Gastoldi S; Imberti B; Perna A; Ruggenenti P; Donadelli R; Benigni A; Remuzzi G
Front Immunol; 2022; 13():827146. PubMed ID: 35320941
[TBL] [Abstract][Full Text] [Related]
15. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
16. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.
Letarov AV; Babenko VV; Kulikov EE
Biochemistry (Mosc); 2021 Mar; 86(3):257-261. PubMed ID: 33838638
[TBL] [Abstract][Full Text] [Related]
17. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant S1 protein with hFc for analysis of SARS-CoV-2 adsorption and evaluation of drugs that inhibit entry into VERO E6 cells.
Couto JCM; Vidal T; Decker ER; Santurio JM; Mello CF; Pillat MM
Immunol Lett; 2023 Nov; 263():105-112. PubMed ID: 37683695
[TBL] [Abstract][Full Text] [Related]
20. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
